Simplex Trading’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Simplex Trading’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,800	Closed	-$4K	–	12014
2021 Q3	$4K	Hold	6,800	–	–	﹤0.01%	9388
2021 Q2	$187K	Buy	6,800 +6,539	+2,505%	+$129K	﹤0.01%	5793
2021 Q1	$430K	Sell	261 -204	-44%	-$4.65K	﹤0.01%	3590
2020 Q4	$856K	Buy	465 +54	+13%	+$966	﹤0.01%	2755
2020 Q3	$559K	Buy	411 +198	+93%	+$3.05K	﹤0.01%	2851
2020 Q2	$381K	Buy	+213	New	+$3.21K	﹤0.01%	3239

Simplex Trading's TBIO Position: Q1 2021 in Review

Simplex Trading sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 13,834 shares — an estimated $315K sold.

Simplex Trading first reported a position in TBIO in Q2 2020 and held it in 3 quarters. The position peaked at $399K in Q2 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

Simplex Trading reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Simplex Trading sold 13,834 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $315K.
Simplex Trading first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Simplex Trading's Translate Bio, Inc. Common Stock position peaked at $399K in Q2 2020.
146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.